Kevin M. Brady - 24 Apr 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Reporting relationship: CFO & Treasurer
Issuer ticker: MEDP
Reported as of: 24 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Apr 2026, 16:42:23 UTC
Prior SEC filing: 25 Nov 2025
Next SEC filing: 24 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen P. Ewald, Attorney-in-Fact for Kevin M. Brady

Key filing fact

Kevin M. Brady filed Form 4 for Medpace Holdings, Inc. (MEDP) on 28 Apr 2026.

Key facts

This page summarizes Kevin M. Brady's Form 4 filing for Medpace Holdings, Inc. (MEDP).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 28 Apr 2026, 16:42.

Change

Previous filing in this sequence was filed on 25 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001877121 Primary reporting owner

Brady Kevin M.

Relationship: CFO & Treasurer
Address: C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
Signature: /s/ Stephen P. Ewald, Attorney-in-Fact for Kevin M. Brady
Signature date: 28 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP transaction

Common Stock

Options Exercise

Transaction value
Shares: +7,000
Change %: +120%
Price: $138.87^*
Shares after: 12,830
Date: 24 Apr 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEDP transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -7,000
Change %: -51%
Price: $0.000000^*
Shares after: 6,803
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,000
Exercise price: $138.87
Footnotes: F1

MEDP transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +10,000
Change %
Price: $0.000000^*
Shares after: 10,000
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $410.54
Footnotes: F2

MEDP transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares: +5,000
Change %
Price: $0.000000^*
Shares after: 5,000
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The option vested in full on February 15, 2026.

Footnote F2

The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

Footnote F4

The restricted stock units vest in full on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.